Business Wire

Mavenir Leads an Open RAN Ecosystem

Del

Mavenir, focused on transforming mobile network economics for communications service providers (CSPs), is announcing an Open RAN partner ecosystem that provides more options and makes it easy for operators to deploy an innovative, flexible Cloud-based Open RAN solution. Mavenir will act as the End-to-End systems integrator simplifying the engagement for operators and creating an offering that is on par with the traditional, hardware centric proprietary vendors.

Ecosystem partners include MTI, Tecore Networks, Baicells, NEC, AceAxis, KMW, Benetel, CommScope, Blue Danube Systems and Airrays.

“Mavenir has always been extremely active in promoting open interfaces as we believe it is in the interest of the CSPs and the overall industry. We will continue to support any effort in the direction of cloud-based architectures and virtualized solutions,” said Pardeep Kohli, President and CEO of Mavenir. “The formation of this ecosystem essentially creates a challenger to the traditional radio vendors. Mavenir would like to encourage any other player to support this effort which will result in a significant disruptive game changer as operators continue to seek a new economic model in a world where a traditional, hardware-based approach is no longer a viable option.”

“This Open RAN ecosystem announcement expands the addressable market for Open RAN solutions,” said Daryl Schoolar, Practice Leader, Service Provider Infrastructure and Software at Ovum. “The ecosystem partners allow for addressing a greater variety of deployment scenarios. End-to-end solution integration makes it easier for smaller operators to deploy these solutions as Mavenir will take on the responsibility of interoperability testing and multi-vendor integration. Smaller operators can lack the internal resources to deploy and manage a multi-vendor network.”

“Global mobile transformation is being defined by 5G, IOT, and subscriber demand for exponential capacity driving new economics and ecosystems, as a partner with Mavenir we are excited to be at the forefront driving a software and open ecosystem,” said Mark Pinto, CEO of Blue Danube.

“The xRAN interoperability testing between Baicells and Mavenir proves that the future of 5G has arrived,” said Minchul Ho, Vice-President of Vertical Sales, Baicells. “The Cloud RAN architecture provides operators several benefits including reduced opex from maintenance, economies of scale efficiencies and vast improved performance due to greater coordination among cells.”

“Achieving seamless Interoperability whilst providing a high level of system flexibility presents a significant challenge to both the RRU vendor and CSP community alike,” said Adrian O’Connor, CEO of Benetel. “However, with the help of these disruptive ecosystem partners and leaders like Mavenir, we will realize an end to end solution in the coming months.”

Interoperability testing has already been conducted based on the xRAN Option 7.2 split specification. Recently, the full xRAN (now ORAN) specifications have been officially released containing the management plane (M-plane), for which Mavenir significantly contributed, making this a complete open specification. Mavenir continues to test the latest version of the Option 7.2 split with the ecosystem partners, who are committed to the Open RAN community and making their solutions commercially available.

This approach is now being favored by Operators who want to embrace Open RAN as it allows the deployment of open market (whitebox) remote radio unit (RRUs) to interwork with the virtualized cloud base band unit (vBBU) over ethernet fronthaul (FH). With this, CSPs can break the stranglehold of closed proprietary specifications and the need to implement dark fiber for RRU fronthaul, which could pose significant economical burdens in some countries. They can continue to provide fronthaul and backhaul in the traditional ways like microwaves and IP/MPLS technologies.

About Mavenir:

Mavenir is purpose-built to redefine mobile network economics for Communication Service Providers (CSPs). Our innovative solutions pave the way to 5G with 100% software-based, end-to-end, Cloud Native network solutions. Leveraging industry-leading firsts in VoLTE, VoWiFi, Advanced Messaging (RCS), Multi-ID, vEPC and Cloud RAN, Mavenir accelerates network transformation for more than 250+ CSP customers in over 130 countries, serving over 50% of the world’s subscribers.

We embrace disruptive, innovative technology architectures and business models that drive service agility, flexibility, and velocity. With solutions that propel NFV evolution to achieve web-scale economics, Mavenir offers solutions to help CSPs with cost reduction, revenue generation and revenue protection. Learn more at mavenir.com.

Mavenir, the M logo, and Cloud Range are trademarks owned by Mavenir Systems, Inc.

Copyright © 2018 Mavenir Systems, Inc. All Rights Reserved.

Contact information

Mavenir
Maryvonne Tubb
PR@mavenir.com
or
MatterNow
Lydia Fakhouri
mavenir@matternow.com
or
GlobalResultsPR
Kevin Taylor
mavenir@globalresultspr.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Telna Launches New eSIM Solution at MWC Barcelona 201924.2.2019 00:00:00Pressemelding

Telna, a vertically integrated Network-as-a-Service (NaaS) provider of global end-to-end connectivity solutions, today is adding eSIM technology to its platform. The new resilient and efficient eSIM architecture will be showcased at Mobile World Congress Barcelona 2019, from February 25th - February 28th at Telna’s booth in Hall 1, Stand 1B80. “eSIM technology is another example of a global trend in digital transformation set to disrupt cellular connectivity,” says Gregory Gundelfinger, CEO of Telna. “Our customers now have access to both Consumer and IoT/M2M eSIM that is bundled with the rest of our software-defined network services.” eSIM is an embedded SIM card, meaning there is no physical SIM card and no physical swapping of SIM cards. It's easy to add data plans and is endorsed by the GSMA. “The virtualization of the SIM card removes one of the largest barriers when switching between networks, the physical SIM card,” says Gundelfinger. The Telna eSIM allows users to access their

Hilton Launches New Brand, Signia Hilton, Delivering Sophisticated Travel While Reimagining Meetings and Events22.2.2019 17:00:00Pressemelding

Hilton (NYSE: HLT) today announced the launch of Signia Hilton, its dynamic, new meetings-and-events-focused brand. The portfolio of hotels is setting out to transform the industry for meeting professionals and sophisticated business travelers by infusing state-of-the-art technology and design into every aspect of the guest experience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190222005071/en/ The brand further reinforces Hilton’s commitment to innovation that meets the evolving needs of today’s travelers and will bring premium experiences to top urban and resort destinations around the world. “In our 100th year of hospitality, we are more focused than ever on providing exceptional experiences to all of our guests – and that includes evolving those experiences to meet their changing needs,” said Christopher J. Nassetta, president and CEO, Hilton. “We are proud to launch Signia Hilton, which exemplifies our innovative sp

Axonics® Granted Expanded CE Mark Label; First and Only Sacral Neuromodulation System Approved for Use with Full-Body MRI Scans22.2.2019 16:30:00Pressemelding

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, announced today that it has received CE mark approval for 1.5T and 3T full-body magnetic resonance imaging (“MRI”) conditional labeling for the Axonics r-SNM® System. The Axonics r-SNM System is the only implantable SNM system that has received full-body MRI conditional labeling for sale in Europe1. Raymond W. Cohen, Chief Executive Officer of Axonics, said, “Without this labeling, any patient requiring an MRI scan on any body part below the head must have their neurostimulator surgically explanted prior to the MRI scan, resulting in an additional surgery for the patient and additional costs to patients and the healthcare system. This authorization of full-body MRI scans in Europe is another important milestone for Axonics, differentiating our te

Fantastec Joins Forces with Arsenal FC Launching Official Blockchain Collectibles App22.2.2019 14:30:00Pressemelding

Fantastec announced today its first football licensing agreement with Premier League club Arsenal FC for a new blockchain authenticated collectibles app called Fantastec SWAP. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190222005277/en/ Arsenal players appear on Fantastec SWAP in official licensing deal (Graphic: Business Wire) London-based Fantastec is a leading sports fan technology innovator, and its blockchain based ‘SWAP’ app will have broad appeal to global sports fans, gamers and sports card collectors alike. Fantastec SWAP unlocks unique and authentic club content through the app, like player autographs and exclusive footage. With its innovative blockchain technology, fans around the world can now discover, collect and swap officially licensed club collectibles with other fans with complete trust. “Fantastec SWAP is a game-changer for international football fans as well the sports collectibles industry,” commented

Volkswagen Protects Virtual Key Sharing App with Trustonic Application Protection22.2.2019 13:42:00Pressemelding

Volkswagen is working with mobile cyber security leader Trustonic to enable customers to use smartphones to access their vehicles, and to securely share their digital car keys to grant access to others via a smartphone app. Volkswagen is using the Trustonic Application Protection (TAP) platform to secure the mobile app and ensure that sensitive information and key transfer requests are securely displayed to, and approved by, a real authenticated user on a trusted device and not by hackers or malware simulating a user or device. “The smartphone is becoming the vehicle key of the future and our We Connect service is the interface for this today in the new Volkswagen Passat,” comments Alf Pollex, Head of Infotainment and Connected Car at Volkswagen AG. “The user installs the We Connect app on their smartphone which is then authorized via the infotainment system with a Transaction Number. The Mobile Key will be compatible with Android-based Samsung devices. No mobile network connection is

Mundipharma EDO GmbH: US FDA grants Orphan Drug Designation for etoposide toniribate in relapsed/refractory biliary tract cancer22.2.2019 13:30:00Pressemelding

Mundipharma EDO GmbH, part of the Mundipharma network of independent associated companies, and Imbrium Therapeutics L.P., an operating subsidiary of Purdue Pharma L.P., today announced that the US FDA has granted Orphan Drug Designation (ODD) to etoposide toniribate for the treatment of relapsed/refractory biliary tract cancer, also known as cholangiocarcinoma.3 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190222005126/en/ Biliary tract cancer is a rare tumour with approximately 8,000 patients diagnosed in the US every year and 10,571 in Europe.4,5 The FDA grants ODD status to medicines intended for the treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the US. Radical surgery is the only curative treatment for biliary tract cancer but, in most cases, the cancer is inoperable. Patients who fail first-line chemotherapy have limited treatment options and the standard of